SCHEMBL1344641

SCHEMBL1344641

Brc1ccccc1-c1cccc2[nH]c3ccccc3c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.52
IMPDH1 P20839 1/20 0.52
CDK4 P11802 4/20 0.48
CCND1 P24385 4/20 0.48
CCNE2 O96020 2/20 0.48
CCNE1 P24864 2/20 0.48
CDK2 P24941 2/20 0.48
CAMK2B Q13554 2/20 0.48
CAMK2G Q13555 2/20 0.48
CAMK2D Q13557 2/20 0.48
CAMK2A Q9UQM7 2/20 0.48
CCNB2 O95067 1/20 0.48
CDK1 P06493 1/20 0.48
CCNB1 P14635 1/20 0.48
PRKACA P17612 1/20 0.48
PRKACG P22612 1/20 0.48
PRKACB P22694 1/20 0.48
CCNB3 Q8WWL7 1/20 0.48
ALDH1A1 P00352 3/20 0.46
GPR3 P46089 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5933739 0.88 IMPDH2 (0.63) IMPDH2IMPDH1CDK4CCND1CCNE2
SCHEMBL1326375 0.86 IMPDH2 (0.61) IMPDH2IMPDH1CDK4CCND1ALDH1A1
SCHEMBL26731069 0.86 IMPDH2 (0.61) IMPDH2IMPDH1CDK4CCND1ALDH1A1
SCHEMBL866840 0.86 IMPDH2 (0.61) IMPDH2IMPDH1CDK4CCND1ALDH1A1
SCHEMBL29724222 0.84 IMPDH2 (0.59) IMPDH2IMPDH1CDK4CCND1CCNE2
SCHEMBL420335 0.84 IMPDH2 (0.59) IMPDH2IMPDH1CDK4CCND1CCNE2
SCHEMBL31259489 0.82 IMPDH2 (0.57) IMPDH2IMPDH1CDK4CCND1CCNE2
SCHEMBL27403957 0.81 IMPDH2 (0.41) IMPDH2IMPDH1CDK4CCND1CCNE2
SCHEMBL20261907 0.81 IMPDH2 (0.55) IMPDH2IMPDH1CDK4CCND1CCNE2
SCHEMBL27097802 0.79 CDK4 (0.56) IMPDH2IMPDH1CDK4CCND1CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024105066-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2024-05-23 WO disclosed
EP-2080762-B1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2016-09-14 EP disclosed
US-8062769-B2 Indolocarbazole compound for use in organic electroluminescent device and organic electroluminescent device NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-11-22 US disclosed
US-20100187977-A1 COMPOUND FOR USE IN ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL CO., LTD. (JP) 2010-07-29 US disclosed
EP-2080762-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE Nippon Steel Chemical Co., Ltd. (JP) 2009-07-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100187977-A1 COMPOUND FOR USE IN ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE LAS1L, LEF1, OXA1L IMPDH2 1818/4885IMPDH1 1291/4885CDK4 1538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.